Not logged inSafety and immunogenicity of a protein subunit COVID-19 vaccine (ZF2001) in healthy children and adolescents aged 3-17years in China: a randomised, double-blind, placebo- controlled, phase 1trial and an open-label, non-randomised, non-inferiority, phase 2 trial
Gao, Lidong; Li, Yan; He, Peng; Chen, Zhen; Yang, Huaiyu; Li, Fangjun; Zhang, Siyuan; Wang, Danni; Wang, Guangyan; Yang, Shilong; Gong, Lihui; Ding, Fan; Ling, Mengyu; Wang, Xilu; Ci, Leilei; Dai, Lianpan; Gao, George Fu; Huang, Tao; Hu, Zhongyu; Ying, Zhifang; Sun, Jiufeng; Zuo, Xiaohu .png)
Share.png)
SaveShare Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
